| 证券代码：002982 | 证券简称：湘佳股份 | 公告编号：2025-034 | | --- | --- | --- | | 债券代码：127060 | 债券简称：湘佳转债 | | 湖南湘佳牧业股份有限公司 2024 年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.本次年度股东大会以现场投票以及网络投票相结合的方式召开； 2.本次股东大会未出现否决提案的情形； 3.本次股东大会未涉及变更前次股东大会决议的情形。 一、会议召开和出席情况 1．会议召开情况 （1）股东大会届次：公司 2024 年度股东大会 （2）股东大会的召集人：董事会 （3）股东大会的主持人：喻自文先生 （4）会议召开的合法、合规性： 本次股东大会的召集、召开符合有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 （5）会议召开的日期、时间： 现场会议召开时间：2025 年 5 月 12 日（星期一）下午 14:30； 网络投票时间： ①通过深圳证券交易所交易系统进行网络投票的时间为：2025 年 5 月 12 日 9:15—9:25,9 ...

湖南启元律师事务所 关于湖南湘佳牧业股份有限公司 2024年度股东大会的 法律意见书 二0二五年五月 湖南启元律师事务所 本律师出具本法律意见书基于公司已作出如下承诺：所有提供给本律师的文 件的正本以及经本律师查验与正本保持一致的副本均为真实、完整、可靠。 为出具本法律意见书，我们依法审核了公司提供的下列资料： 1 、公司于 2025 年 4 月 19 日发布在深圳证券交易所网站 （http://www.szse.cn）上的公司第五届董事会第十二次会议决议的公告（以下 简称"董事会决议"）以及关于召开本次股东大会通知的公告（以下简称"股东 大会通知"）。 2、出席会议股东或其代理人的资格、身份证明文件等。 根据中国证券监督管理委员会发布的《股东会规则》第六条的有关规定，现 出具法律意见如下： 一、本次股东大会的召集程序 关于湖南湘佳牧业股份有限公司 2024 年度股东大会的法律意见书 致：湖南湘佳牧业股份有限公司 湖南启元律师事务所接受湖南湘佳牧业股份有限公司（以下简称"公司"） 的委托，指派律师出席了公司 2024 年度股东大会（以下简称"本次股东大会"）， 对会议进行现场律师见证，并出具本法律意见书。 本 ...

Group 1 - Dashi Intelligent signed a smart hospital project contract worth 58.12 million yuan with the First Affiliated Hospital of Bengbu Medical College and Bengbu Urban Construction Investment Development Co., Ltd. [1] - The project aims to create a comprehensive tumor specialty hospital integrating medical care, research, teaching, preventive health care, and rehabilitation, which is expected to positively impact the company's future performance [1] Group 2 - Huahong Company reported a net profit of 22.76 million yuan for Q1 2025, a year-on-year decrease of 89.73%, despite a revenue increase of 18.66% to 3.913 billion yuan [2] - The company specializes in the development and application of embedded/non-volatile memory, power devices, and other semiconductor technologies [2] Group 3 - Jindi Group announced a signed area of 214,000 square meters in April, a year-on-year decrease of 55.14%, with a signed amount of 2.78 billion yuan, down 55.45% [3] - The company focuses on real estate development and sales, commercial real estate, and property management [3] Group 4 - Jinlong Automobile reported a bus production of 4,361 units in April, a year-on-year decrease of 5.79%, with sales of 3,611 units, down 3.91% [4][5] - The company is engaged in the production and sales of bus products [5] Group 5 - Sanyou Medical established a joint venture with CGBio Co., Ltd. with a registered capital of 60 million yuan, focusing on innovative cell biological materials and regenerative medicine [6][7] - The company specializes in the research, production, and sales of orthopedic implant consumables [7] Group 6 - Jinzhi Technology won a bid for projects related to the State Grid with a total amount of 90.73 million yuan, accounting for 5.12% of the company's projected revenue for 2024 [9][10] - The company focuses on smart energy and smart city businesses [10] Group 7 - Pinggao Electric won multiple procurement projects from the State Grid, totaling approximately 1.751 billion yuan, which is 14.12% of the company's projected revenue for 2024 [10] - The company specializes in high-voltage switchgear and power engineering contracting [10] Group 8 - Luantang Pharmaceutical received approval for the raw material drug Celecoxib, which is a selective COX-2 inhibitor with fewer gastrointestinal side effects compared to traditional NSAIDs [11][12] - The company is involved in the research, production, and sales of pharmaceutical products [12] Group 9 - Dongjie Intelligent obtained seven patent certificates related to AGV and conveyor system technologies [13][14] - The company specializes in the research, design, manufacturing, installation, and debugging of intelligent logistics systems [14] Group 10 - XJH Holdings received a government subsidy of 8.69 million yuan, which accounts for 38.67% of the company's projected net profit for 2024 [15][16] - The company focuses on the recycling and dismantling of waste electrical products [16] Group 11 - Huaihua Pharmaceutical's subsidiary received approval for the clinical trial of HZ-J001 ointment for treating non-segmental vitiligo [17][19] - The company is engaged in the research, production, and sales of pharmaceutical products [19] Group 12 - ST Aonong reported a pig sales volume of 132,800 heads in April, a year-on-year decrease of 14.42%, while the stock of pigs increased by 15.06% [22][23] - The company is involved in feed, pig farming, food, and trade [23] Group 13 - Beibu Gulf Port reported a cargo throughput of 31.75 million tons in April, a year-on-year increase of 20.32% [24][25] - The company specializes in port loading, storage, and related services [25] Group 14 - Dongfang Iron Tower won a bid for State Grid projects totaling approximately 100 million yuan, which is 2.39% of the company's projected revenue for 2024 [26] - The company focuses on steel structures and related businesses [26] Group 15 - Huanxu Electronics reported a consolidated revenue of 4.641 billion yuan in April, a year-on-year increase of 0.72% [27] - The company provides design, manufacturing, and related services for brand customers [27] Group 16 - Jincheng Co. announced that part of its bank accounts has been frozen, involving approximately 32.97 million yuan due to contract disputes [28][29] - The company specializes in high-end intelligent equipment for photovoltaic and smart port sectors [29] Group 17 - NAIKE Equipment announced the departure of core technical personnel Wang Xiangguo [30][31] - The company focuses on semiconductor packaging equipment and related products [31] Group 18 - Jiaojian Co. won a construction project in Hefei with a bid amount of approximately 704 million yuan, covering residential buildings and related infrastructure [32][33] - The company specializes in infrastructure construction and related services [33] Group 19 - Hongyuan Green Energy plans to transfer a 27.07% stake in Inner Mongolia Xinyuan Silicon Material Technology Co., Ltd. for 1.245 billion yuan [34][35] - The company focuses on the research, production, and sales of aviation electromechanical products [35] Group 20 - Poly Development reported a signed amount of 24.622 billion yuan in April, a year-on-year decrease of 25.44% [46][48] - The company specializes in real estate development and sales [48]

| 证券代码：002982 | 证券简称：湘佳股份 | 公告编号：2025-033 | | --- | --- | --- | | 债券代码：127060 | 债券简称：湘佳转债 | | 湖南湘佳牧业股份有限公司 2025 年 4 月份活禽销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、2025 年 4 月份活禽销售情况 湖南湘佳牧业股份有限公司（以下简称"公司"）2025 年 4 月份销售活禽 443.67 万只，销售收入 8,070.27 万元，销售均价 9.26 元/公斤，环比变动分别 为 17.46%、12.62%、-1.21%，同比变动分别为 73.57%、42.86%、-18.20%。 2025 年 4 月份公司活禽销售量及金额同比上升较多，主要是 2024 年 2 月份 公司遭受雪灾后部分养殖场需要修缮，禽苗放养量减少所致。 四、特别提示 1、上述财务数据均未经审计，可能与公司定期报告披露的数据存在一定差 异，敬请广大投资者谨慎决策，注意投资风险。 注：若存在尾差，属四舍五入原因所致。 月份 活禽销量（万只） 销售收入（万元） ...

Group 1 - The company Xiangjia Co., Ltd. (002982) reported sales of live poultry reaching 4.4367 million units in April 2025, generating a revenue of 80.7027 million yuan, with an average selling price of 9.26 yuan per kilogram [1] - Month-on-month changes in sales volume, revenue, and average price were 17.46%, 12.62%, and -1.21% respectively [1] - Year-on-year changes in sales volume, revenue, and average price were 73.57%, 42.86%, and -18.20% respectively [1]

关于实际控制人续签一致行动协议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 | 证券代码：002982 | 证券简称：湘佳股份 | 公告编号：2025-032 | | --- | --- | --- | | 债券代码：127060 | 债券简称：湘佳转债 | | 湖南湘佳牧业股份有限公司 湖南湘佳牧业股份有限公司（以下简称"公司"）的实际控制人喻自文先 生、邢卫民先生签署的《一致行动协议》已于近日到期，基于对公司长远发展的 信心，为保持公司重大事项决策的一致性，保障公司持续稳健发展，喻自文先生、 邢卫民先生于 2025 年 4 月 28 日续签了《一致行动协议》，继续作为一致行动人。 具体情况公告如下： 一、协议签署情况概述 喻自文先生、邢卫民先生为公司实际控制人，自愿《一致行动协议》签署至 今，双方持续保持良好的合作关系，相互尊重各方意见，事先进行充分沟通与协 商，就有关公司经营发展的重大事项向股东大会行使提案权和表决权时均保持一 致意见。 喻自文先生、邢卫民先生基于对公司长远发展的信心，为保持公司重大事项 决策的一致性，保障公司持续稳健发展，于 ...

Financial Performance - The company reported a basic earnings per share of 0.2400 yuan for Q1 2025, a significant increase of 271.43% compared to -0.1400 yuan in Q1 2024 [1] - Net profit for Q1 2025 was 0.35 billion yuan, showing a remarkable growth of 284.21% from a loss of -0.19 billion yuan in Q1 2024 [1] - Operating revenue reached 10.78 billion yuan in Q1 2025, representing a year-on-year increase of 19.12% from 9.05 billion yuan in Q1 2024 [1] - The return on equity (ROE) improved to 1.98% in Q1 2025, compared to -1.18% in Q1 2024, indicating a positive turnaround [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 36.89 million shares, accounting for 39.77% of the circulating shares, with a decrease of 3.4766 million shares from the previous period [2] - Major shareholders include Yu Ziwen and Xing Weimin, each holding 8.68% of the total share capital, with no change in their holdings [3] - Hunan Dajing Shuangjia Investment Enterprise (Limited Partnership) saw a reduction of 3.4747 million shares, now holding 7.82% of the total share capital [3] Dividend Policy - The company has decided not to distribute dividends or transfer shares in the current period [3]

Financial Performance - The company's revenue for Q1 2025 reached ¥1,077,744,971.60, representing a 19.06% increase compared to ¥905,192,052.83 in the same period last year[5] - Net profit attributable to shareholders was ¥34,543,082.87, a significant turnaround from a loss of ¥19,412,531.26, marking a 277.94% increase[5] - The net profit after deducting non-recurring gains and losses was ¥25,250,572.99, up 272.11% from a loss of ¥14,671,387.48 in the previous year[5] - Basic and diluted earnings per share improved to ¥0.24 from a loss of ¥0.14, reflecting a 271.43% increase[5] - The net profit for the current period is 33,377,553.00, compared to a net loss of 22,498,222.59 in the previous period, indicating a significant turnaround[20] - Operating profit for the current period is 37,188,829.35, while the previous period reported an operating loss of 10,240,359.97, reflecting improved operational efficiency[20] - Total comprehensive income for the current period is 33,377,553.00, compared to a comprehensive loss of 22,498,222.59 in the previous period, indicating a strong recovery[20] Assets and Liabilities - The company's total assets increased by 1.62% to ¥4,234,222,289.33 from ¥4,166,733,797.65 at the end of the previous year[5] - Current assets totaled ¥1,353,382,175.40, slightly up from ¥1,349,124,166.40, showing a marginal increase of 0.2%[15] - Non-current assets increased to ¥2,880,840,113.93 from ¥2,817,609,631.25, representing a growth of about 2.2%[16] - Total liabilities amounted to ¥2,422,403,807.40, up from ¥2,359,266,527.94, reflecting an increase of about 2.7%[16] - Shareholders' equity totaled ¥1,811,818,481.93, slightly increasing from ¥1,807,467,269.71, indicating a growth of around 0.2%[16] - The company reported a decrease in short-term borrowings to ¥260,000,000.00 from ¥303,409,468.41, a reduction of approximately 14.3%[16] Cash Flow - Cash flow from operating activities decreased by 15.08% to ¥43,295,351.20 compared to ¥50,981,566.22 in the same period last year[5] - The net cash flow from operating activities is 43,295,351.20, down from 50,981,566.22 in the previous period, indicating a decrease of about 15.5%[22] - Cash and cash equivalents at the end of the period stand at 416,204,742.17, slightly up from 412,786,121.63 in the previous period, indicating stable liquidity[22] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 15,933, with no preferred shareholders[11] - The top two shareholders, Yu Ziwen and Xing Weimin, each hold 22.19% of the shares, totaling 32,200,000 shares[11] Operating Costs and Expenses - Total operating costs amounted to ¥1,051,021,093.95, up from ¥920,843,822.63, reflecting a rise of approximately 14.2%[18] - Operating costs specifically rose to ¥918,692,695.39, compared to ¥777,078,659.11, indicating a significant increase of 18.2%[18] - The company incurred research and development expenses of 7,998,452.98, slightly down from 8,242,583.19 in the previous period, reflecting a focus on cost management[20] - The company reported a significant increase in sales expenses, totaling 89,104,560.30, down from 99,725,216.52 in the previous period, which may suggest improved marketing efficiency[20] Market Strategy - The company is focusing on expanding its market presence and developing new products, although specific figures were not disclosed in the call[17] Audit Status - The company has not undergone an audit for the first quarter report, which may affect investor confidence in the reported figures[24]

何业春向《证券日报》记者透露："公司投资建设的美食心动超级智能工厂(一期)将于2025年5月份投 产，达产后年产能将有8万吨，带有全产业链食品标签的石门肥肠、口味鸡杂、石门土鸡钵等预制菜将 带给广大城镇居民新鲜安全美味佳肴，这将打开公司新一轮增长的空间。" 湖南惠农科技有限公司大数据分析师李彬彬向《证券日报》记者表示："当前黄羽鸡的全社会产能处于 历史低位，若2025年消费需求复苏，行业或迎来新一轮价格上涨周期。湘佳股份正加速向食品加工企业 转型，冰鲜屠宰、预制菜及蛋鸡出口构成新的业绩增长'铁三角'。在消费升级与农业新质生产力发展的 双重驱动下，湘佳股份的案例为传统养殖企业转型升级提供了鲜活样本。" 不仅是饲料成本下降为扭亏为盈作出贡献，湘佳股份的冰鲜业务占比提升，也优化了高毛利产品结构， 叠加公司冷链物流体系的支撑，成为利润增长的重要来源。此外，湘佳股份与国内外头部商超企业的战 略合作，进一步巩固了终端市场优势。为了巩固公司取得的市场份额，湘佳股份配置了50余台冷链车， 可在18个小时内覆盖全国。2024年，湘佳股份还主动延伸产业链，开始进入熟食领域，主要以家禽和猪 肉为食材，目前已研发产品包括盐焗、烧腊、 ...

经湖南湘佳牧业股份有限公司（以下简称"公司"）第五届董事会第十二次 会议审议通过，公司将于 2025 年 5 月 12 日（星期一）召开 2024 年度股东大会， 现将有关事项通知如下： 一、召开会议的基本情况 1、股东大会届次：2024 年度股东大会 | 证券代码：002982 | 证券简称：湘佳股份 | 公告编号：2025-029 | | --- | --- | --- | | 债券代码：127060 | 债券简称：湘佳转债 | | 湖南湘佳牧业股份有限公司 关于召开 2024 年度股东大会通知的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 2、股东大会的召集人：公司董事会 3、会议召开的合法、合规性：本次股东大会的召开符合有关法律、行政法 规、部门规章、规范性文件、交易所业务规则和《公司章程》等的规定。 4、会议召开的日期、时间： （1）现场会议召开时间：2025 年 5 月 12 日（星期一）下午 14:30 （2）网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 12 日 9:15—9:25,9:30— ...